Advanced search×

Ehlers-Danlos syndrome.

Frances F Gawthrop, Rae R Mould, Amanda A Sperritt, and Fiona F Neale

BMJ 335(7617):448-50 (2007) PMID 17762038 PMCID 1962838

Version: za2963e q8za0 q8zb0 q8zcb q8zd1 q8ze1 q8zfb q8zg0
Buy PDF

Similar articles you may find interesting…

  1. Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding.
    Kazunori Mizuno, Sergei Boudko, and Hans Peter Bachinger

    J Biol Chem (2013) PMID 23645670

    We used this system for the two known EDS mutations (Gly-to-Val) in the middle at G910 and at the C-terminus at G1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is m...
    PDF not found
  2. Angiotensin II Promotes Thoracic Aortic Dissections and Ruptures in Col3a1 Haploinsufficient Mice.
    Julie Faugeroux, Hany Nematalla, and Sonia Bergaya

    Hypertension (2013) PMID 23630948

    Our objective was to determine the susceptibility of Col3a1(+/-) mice to develop arterial ruptures under high blood pressure (BP) conditions induced by a 4-week infusion of angiotensin II (AngII). AngII (1 μg/kg per minute) significantly and comparably increased systolic BP in Col3a1(+/-) and Col3a...
    Buy PDF
  3. Mitral valve endocarditis in a patient with Ehlers-Danlos syndrome.
    Ioannis Koukis, Jennifer Kingston, and Brian Prendergast

    Gen Thorac Cardiovasc Surg (2013) PMID 23625151

    We report a patient with Ehlers-Danlos syndrome and mitral valve endocarditis. The case was complicated due to the initial septic status of the patient and the fragility of the mitral valve both of which required further early operative intervention. The patient also had pre-existing pulmonary septi...
    Buy PDF